06-Apr-2021
Download PDF
Aurobindo Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 06 2021 for Axis Clinic Ltd Trident Chemphar Ltd & RPR Sons Advisors Pvt Ltd. (Jointly holding)
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
